CARD9 and colitis: Human SNPs in CARD9 have been identified as risk factors for IBD by several GWAS-based studies (discussed below), and animal models have shown that CARD9 promotes the production of pro-inflammatory cytokines IL-1β and IL-22 in the gut during active colitis, which in turn drives colonic tumor growth (37).